Article
Molecular intelligence and immune reconnaissance in thyroid cancer: a new paradigm for diagnosis, risk stratification, and therapeutic precision.
Expert review of anticancer therapy - 1 May 2026
Concepción-Zavaleta Marcio J, Fuentes-Mendoza Jenyfer M, Cruz-Quintá Alfredo, Cadena-Guerrero Argelia V, Barrón Ximena, Concepción-Urteaga Luis, D Armas Cristian, Paz-Ibarra José, Quiroz-Aldave Juan Eduardo
Abstract excerpt
INTRODUCTION: Thyroid cancer management is shifting from morphology-based assessment to precision oncology driven by integrated molecular profiling and computational analytics. This review examines how these advances address overdiagnosis, indeterminate cytology, and radioiodine-refractory disease. AREAS COVERED: We synthesize recent evidence on multi-analyte next-generation sequencing panels, the prognostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
